OpenAlex
PricingAboutJobs
Log inGet started
Work

Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?

HTML

Year: 2011
Type: review
Source: Clinical Infectious Diseases
DOI: 10.1093/cid/cir184
Authors: J. van Ingen, R. E. Aarnoutse, P. R. Donald, A. H. Diacon, R. Dawson, G. Plemper van Balen, S. H. Gillespie, M. J. Boeree
Institutions: Radboud University Nijmegen, Radboud University Medical Center, Stellenbosch University, University of Cape Town, University of St Andrews
Language: English

Topic: Tuberculosis Research and Epidemiology
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Keywords: rifampicin, tuberculosis treatment, once-daily dosing, dose-response relationship, pharmacokinetics, minimum inhibitory concentration, adverse drug reactions, bactericidal activity, Mycobacterium tuberculosis, dose optimization
SDG: Good health and well-being

Open Access status: closed

Funder: European and Developing Countries Clinical Trials Partnership
OpenAlex ID: W2129441585
FWCI: 1.374
Cites: 48
Cited by: 278
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security